Literature DB >> 2651479

Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.

R Jacob1, E Barrett, G Plewe, K D Fagin, R S Sherwin.   

Abstract

To elucidate the acute metabolic actions of insulin-like growth factor I (IGF-I), we administered a primed (250 micrograms/kg), continuous (5 micrograms/kg.min) infusion of human recombinant (Thr 59) IGF-I or saline to awake, chronically catheterized 24-h fasted rats for 90 min. IGF-I was also infused while maintaining euglycemia (glucose clamp technique) and its effects were compared to those of insulin. IGF-I infusion caused a twofold rise in IGF-I levels and a 75-85% decrease in plasma insulin. When IGF-I alone was given, plasma glucose fell by 30-40 mg/dl (P less than 0.005) due to a transient twofold increase (P less than 0.05) in glucose uptake; hepatic glucose production and plasma FFA levels remained unchanged. IGF-I infusion with maintenance of euglycemia produced a sustained rise in glucose uptake and a marked stimulation of [3-3H]glucose incorporation into tissue glycogen, but still failed to suppress glucose production and FFA levels. IGF-I also produced a generalized 30-40% reduction in plasma amino acids, regardless of whether or not hypoglycemia was prevented. This was associated with a decrease in leucine flux and a decline in the incorporation of [1-14C]leucine into muscle and liver protein (P less than 0.05). When insulin was infused in a dosage that mimicked the rise in glucose uptake seen with IGF-I, nearly identical changes in amino acid metabolism occurred. However, insulin suppressed glucose production by 65% and FFA levels by 40% (P less than 0.001). Furthermore, insulin was less effective than IGF-I in promoting glycogen synthesis. We conclude that (a) IGF-I produces hypoglycemia by selectively enhancing glucose uptake; (b) IGF-I is relatively ineffective in suppressing hepatic glucose production or FFA levels; and (c) IGF-I, like insulin, lowers circulating amino acids by reducing protein breakdown rather than by stimulating protein synthesis. Thus, IGF-I's metabolic actions in fasted rats are readily distinguished from insulin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651479      PMCID: PMC303881          DOI: 10.1172/JCI114072

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Effect of epinephrine on rat diaphragm.

Authors:  O WALAAS; E WALAAS
Journal:  J Biol Chem       Date:  1950-12       Impact factor: 5.157

2.  In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies.

Authors:  D Smith; L Rossetti; E Ferrannini; C M Johnson; C Cobelli; G Toffolo; L D Katz; R A DeFronzo
Journal:  Metabolism       Date:  1987-12       Impact factor: 8.694

3.  Effect of insulin-like growth factor on collagen and glycosaminoglycan synthesis by rabbit articular chondrocytes in culture.

Authors:  H L Guenther; H E Guenther; E R Froesch; H Fleisch
Journal:  Experientia       Date:  1982-08-15

4.  Insulin-like growth factor I stimulates growth in hypophysectomized rats.

Authors:  E Schoenle; J Zapf; R E Humbel; E R Froesch
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

5.  Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis.

Authors:  P Castellino; L Luzi; D C Simonson; M Haymond; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  Role of insulin in the regulation of leucine kinetics in the conscious dog.

Authors:  N N Abumrad; L S Jefferson; S R Rannels; P E Williams; A D Cherrington; W W Lacy
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

7.  Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I.

Authors:  E Scheiwiller; H P Guler; J Merryweather; C Scandella; W Maerki; J Zapf; E R Froesch
Journal:  Nature       Date:  1986 Sep 11-17       Impact factor: 49.962

8.  Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults.

Authors:  H P Guler; J Zapf; E R Froesch
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

9.  Studies of acute effects of insulin-like growth factors I and II in human fat cells.

Authors:  J Bolinder; A Lindblad; P Engfeldt; P Arner
Journal:  J Clin Endocrinol Metab       Date:  1987-10       Impact factor: 5.958

10.  Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver.

Authors:  J F Caro; J Poulos; O Ittoop; W J Pories; E G Flickinger; M K Sinha
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

View more
  49 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Avoiding autocannibalism.

Authors:  R J Ross; J P Miell; C R Buchanan
Journal:  BMJ       Date:  1991-11-09

3.  In vivo metabolic action of insulin-like growth factor I in adult rats.

Authors:  F Schmitz; H Hartmann; F Stümpel; W Creutzfeldt
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

4.  Effects of insulin-like growth factor I on basal and stimulated glucose fluxes in rat liver.

Authors:  R Englisch; R Wurzinger; C Fürnsinn; B Schneider; H Frisch; W Waldhäusl; J Graf; M Roden
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

Review 5.  The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.

Authors:  R J Ross; J Rodriguez-Arnao; J Bentham; J H Coakley
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 6.  The GH/IGF-1 system in critical illness.

Authors:  Itoro E Elijah; Ludwik K Branski; Celeste C Finnerty; David N Herndon
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-10       Impact factor: 4.690

Review 7.  The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus.

Authors:  Venu Gopal Jonnalagadda; Allam Venkata Sita Ram Raju; Srinivas Pittala; Afsar Shaik; Nilakash Annaji Selkar
Journal:  Adv Pharm Bull       Date:  2014-02-07

8.  Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.

Authors:  F M Tomas; S E Knowles; P C Owens; C S Chandler; G L Francis; F J Ballard
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

Review 9.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

10.  Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.

Authors:  R Laager; R Ninnis; U Keller
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.